Serum biomarkers predict acute symptom burden in children after concussion: A preliminary study

Journal of Neurotrauma

Volumn 31, Issue 11, 2014, Pages 1072-1075

  Mannix, Rebekah ^a,b   Eisenberg, Matthew ^a,b   Berry, Mark ^a   Meehan, William P ^a,b,c   Hayes, Ronald L ^d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Harvard Medical School   (United States)

^d BANYAN BIOMARKERS INC   (United States)

Author keywords

biomarkers; concussion; traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADOLESCENT; ARTICLE; BRAIN CONCUSSION; CHILD; CLINICAL ARTICLE; EMERGENCY WARD; FEMALE; FOLLOW UP; HUMAN; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SYMPTOMATOLOGY; AMNESIA; BLOOD; COST OF ILLNESS; POST-CONCUSSION SYNDROME; PREDICTIVE VALUE; PSYCHOLOGY; UNCONSCIOUSNESS;

ADOLESCENT; AMNESIA; BIOLOGICAL MARKERS; BRAIN CONCUSSION; CHILD; COST OF ILLNESS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; POST-CONCUSSION SYNDROME; PREDICTIVE VALUE OF TESTS; UNCONSCIOUSNESS;

EID: 84901983197     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.3265     Document Type: Article

References (17)

1. Langlois, J.A., Rutland-Brown, W., Wald, M. (2006). The epidemiology and impact of traumatic brain injury: a brief overview. J. Head Trauma Rehabil. 21, 375-378.
2. Bakhos, L.L., Lockhart, G.R., Myers, R., and Linakis, J.G. (2010). Emergency department visits for concussion in young child athletes. Pediatrics 126, e550-e556.
3. Meehan, W.P., 3rd, d'Hemecourt, P., and Comstock, R.D. (2010). High school concussions in the 2008-2009 academic year: mechanism, symptoms, and management. Am. J. Sports Med. 38, 2405-2409.
4. Zonfrillo, M.R., Master, C.L., Grady, M.F., Winston, F.K., Callahan, J.M., and Arbogast, K.B. (2012). Pediatric providers' self-reported knowledge, practices, and attitudes about concussion. Pediatrics 130, 1120-1125.
5. Beers, S.R., Berger, R.P., and Adelson, P.D. (2007). Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children. J. Neurotrauma 24, 97-105.
6. Berger, R.P., Adelson, P.D., Pierce, M.C., Dulani, T., Cassidy, L.D., and Kochanek, P.M. (2005). Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. J. Neurosurg. 103, 61-68.
7. Geyer, C., Ulrich, A., GrAfe, G., Stach, B., and Till, H. (2009). Diagnostic value of S100B and neuron-specific enolase in mild pe-diatric traumatic brain injury. J. Neurosurg. Pediatr. 4, 339-344.
8. Metting, Z., Wilczak, N., Rodiger, L.A., Schaaf, J.M., and van der Naalt, J. (2012). GFAP and S100B in the acute phase of mild trau matic brain injury. Neurology 78, 1428-1433.
9. Okonkwo, D.O., Yue, J.K., Puccio, A.M., Panczykowski, D., Inoue, T., McMahon, P.J., Sorani, M.D., Yuh, E.L., Lingsma, H., Maas, A., Valadka, A., et al. (2013). GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective TRACK-TBI Study. J. Neurotrauma 30, 1490-1497.
10. Papa, L., Lewis, L.M., Falk, J.L., Zhang, Z., Silvestri, S., Giordano, P., Brophy, G.M., Demery, J.A., Dixit, N.K., Ferguson, I., Liu, M.C., Mo, J., Akinyi, L., Schmid, K., Mondello, S., Robertson, C.S., Tortella, F.C., Hayes, R.L., and Wang, K.K. (2012). Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracra-nial lesions and neurosurgical intervention. Ann. Emerg. Med. 59, 471-483.
11. Diaz-Arrastia, R., Wang, K.K., Papa, L., Sorani, M.D., Yue, J.K., Puccio, A.M., McMahon, P.J., Inoue, T., Yuh, E.L., Lingsma, H.F., Maas, A.I., Valadka, A.B., Okonkwo, D.O., Manley, G.T., Casey, S.S., Cheong, M., Cooper, S.R., Dams-O'Connor, K., Gordon, W.A., Hricik, A.J., Menon, D.K., Mukherjee, P., Schnyer, D.M., Sinha, T.K., and Vassar, M.J. (2014). Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubi-quitin C-terminal hydrolase-l1 and glial fibrillary acidic protein. J. Neurotrauma 31, 19-25.
12. Czeiter, E., Mondello, S., Kovacs, N., Sandor, J., Gabrielli, A., Schmid, K., Tortella, F., Wang, K.K., Hayes, R.L., Barzo, P., Ezer, E., Doczi, T., and Buki, A. (2012). Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. J. Neuro-trauma 29, 1770-1778.
13. Gioia, G.A., Schneider, J.C., Vaughan, C.G., and Isquith, P.K. (2009). Which symptom assessments and approaches are uniquely appropriate for paediatric concussion? Br. J. Sports Med. 43, Suppl. 1, i13-22.
14. King, N.S., Crawford, S., Wenden, F.J., Moss, N.E., and Wade, D.T. (1995). The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J. Neurol. 242, 587-592.
15. Eisenberg, M.A., Andrea, J., Meehan, W., and Mannix, R. (2013). Time interval between concussions and symptom duration. Pediatrics 132, 8-17.
16. Babcock, L., McClanahan, N., Ho, M., Hornung, R., and Wade, S. (2013). UCHL-1 and GFAP: Are these promising acute diagnostic biomarkers for children with mild traumatic brain injury? American Academy of Pediatrics Conference: Orlando, FL, October 25, 2013.
17. Fraser, D.D., Close, T.E., Rose, K.L., Ward, R., Mehl, M., Farrell, C., Lacroix, J., Creery, D., Kesselman, M., Stanimirovic, D., and Hutchison, J.S. (2011). Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum. Pediatr. Crit. Care Med. 12, 319-324.